Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon‐alpha‐2a: A study by the Italian trials in Medical Oncology Group

Background. Using a wide range of interferon (IFN) doses and schedules, a number of authors have found them to be active against neuroendocrine tumors.

[1]  W. Huttner,et al.  Argyrophilia and Granin (Chromogranin/Secretogranin) Expression in Female Breast Carcinomas Their Relationship to Survival and Other Disease Parameters , 1992, The American journal of surgical pathology.

[2]  F. Rilke,et al.  Well-Differentiated Neuroendocrine Carcinoma of the Lung: A Clinicopathologic and Ultrastructural Study of 10 Cases , 1992, Tumori.

[3]  S. Lipsitz,et al.  Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. , 1992, The New England journal of medicine.

[4]  D. Wynick,et al.  Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors. , 1991, The Journal of clinical endocrinology and metabolism.

[5]  E. Kumpulainen,et al.  Response of medullary thyroid cancer to low-dose alpha-interferon therapy. , 1990, Acta oncologica.

[6]  L. Kvols,et al.  Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Schrumpf,et al.  RECOMBINANT a-2 INTERFERON WITH OR WITHOUT HEPATIC ARTERY EMBOLIZATION IN THE TREATMENT OF MIDGUT CARCINOID TUMOURS , 1989 .

[8]  I. Gresser.  Antitumor effects of interferon. , 1989, Acta oncologica.

[9]  H. Strander.  Clinical effects of interferon therapy with special emphasis on antitumor efficacy. , 1989, Acta oncologica.

[10]  E. Schrumpf,et al.  Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report. , 1989, Acta oncologica.

[11]  C. Bartoli,et al.  Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Bukowski,et al.  A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A southwest oncology group study , 1987, Cancer.

[13]  R. Johnston,et al.  Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor. , 1987, Cancer treatment reports.

[14]  L. Kvols,et al.  Chemotherapy of endocrine malignancies: a review. , 1987, Seminars in oncology.

[15]  G. Sassolas,et al.  Clinical and hormonal effects of a long‐acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome , 1987, Cancer.

[16]  E. Wilander,et al.  Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. , 1987, Cancer treatment reports.

[17]  M. O’connell,et al.  Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. , 1986, Cancer treatment reports.

[18]  D. Schoenfeld,et al.  A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma , 1985, Cancer.

[19]  P. Lavin,et al.  Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  C. Moertel.  Treatment of the carcinoid tumor and the malignant carcinoid syndrome. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Öberg,et al.  Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. , 1983, The New England journal of medicine.

[22]  A. Kessinger,et al.  Therapy of malignant APUD cell tumors: Effectiveness of DTIC , 1983, Cancer.

[23]  Moertel Cg,et al.  Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. , 1979 .

[24]  J. Hanley,et al.  Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. , 1979, Cancer clinical trials.

[25]  I. Gresser.  The antitumor effects of interferon , 1986, Biochimica et biophysica acta.

[26]  I. Dawson.  Histological Typing of Intestinal Tumours. International Histological Classification of Tumours , 1977 .

[27]  T. Berge,et al.  Carcinoid tumours. Frequency in a defined population during a 12-year period. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[28]  J. Godwin.  Carcinoid Tumors An analysis of 2837 cases , 1975, Cancer.

[29]  S. Carter,et al.  Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. , 1973, Annals of internal medicine.